
Tactile Systems (TCMD) Stock Forecast & Price Target
Tactile Systems (TCMD) Analyst Ratings
Bulls say
Tactile Systems Tech is a medical technology company that has a positive outlook due to strong growth in lymphedema and airway clearance, a focus on sales and technology investment, improved market conditions, and recent acquisitions. With a strong position in the advanced compression market and a projected 9-12% increase in revenue for FY26, TCMD has a Buy rating and potential upside from increased sales and improved rep productivity. Challenges such as slower uptake in commercial channels and competition exist, but the company remains confident in their growth potential driven by new product cycles and improved sales productivity.
Bears say
Tactile Systems Tech is experiencing positive sales growth and expanding in new product lines, but their competition within the Airway Clearance market and increasing operating expenses may limit their overall profitability. Furthermore, the recent acquisition of LymphaTech aims to drive higher diagnosis of lymphedema, but it is uncertain if it will significantly impact overall sales. Overall, while the outlook for Tactile Systems Tech looks promising, the potential challenges in the market and their increased expenses lead to a negative outlook for the company.
This aggregate rating is based on analysts' research of Tactile Systems and is not a guaranteed prediction by Public.com or investment advice.
Tactile Systems (TCMD) Analyst Forecast & Price Prediction
Start investing in Tactile Systems (TCMD)
Order type
Buy in
Order amount
Est. shares
0 shares